nnpNeurology, Neuropsychiatry, PsychosomaticsНеврология, нейропсихиатрия, психосоматика2074-27112310-1342"IMA-Press", LLC10.14412/2074-2711-2026-3-85-92nnp-2863Research ArticleCLINICAL OBSERVATIONSКЛИНИЧЕСКИЕ НАБЛЮДЕНИЯThe integration of new dosage forms into the treatment of vascular cognitive impairmentИнтеграция новых лекарственных форм в лечение сосудистых когнитивных нарушенийhttps://orcid.org/0000-0002-8447-3264ЗахаровВ. В.ZakharovV. V.

Владимир Владимирович Захаров 

119021, Москва, ул. Россолимо, 11, стр. 1 

Vladimir Vladimirovich Zakharov 

11, Rossolimo St., Build. 1, Moscow 119021 

zakharovenator@gmail.comhttps://orcid.org/0000-0002-3016-540XМартыноваО. О.MartynovaO. O.

115409, ул. Москворечье, 16 

16, Moskvorechye St., Moscow, 115409 

Кафедра нервных болезней Института клинической медицины им. Н.В. Склифосовского ФГАОУ ВО «Первый Московский медицинский университет им. И.М. Сеченова» Минздрава России (Сеченовский Университет)РоссияDepartment of Nervous Diseases, N.V. Sklifosovsky Institute of Clinical Medicine, I.M. Sechenov First Moscow State Medical University, Ministry of Health of Russia (Sechenov University)Russian FederationФГБУЗ «Клиническая больница №85 ФМБА России»РоссияClinical Hospital № 85 of the Federal Medical Biological AgencyRussian Federation2026200620261838592Copyright © Zakharov V.V., Martynova O.O., 20262026Захаров В.В., Мартынова О.О.Zakharov V.V., Martynova O.O.Данная работа распространяется под лицензией Creative Commons Attribution 4.0.This work is licensed under a Creative Commons Attribution 4.0 License.https://nnp.ima-press.net/nnp/article/view/2863

This article reviews current approaches to the diagnosis and treatment of vascular cognitive impairment (VCI). It outlines the key provisions of the updated diagnostic criteria for vascular cognitive impairment from the international VasCog-2-WSO society (2025) and the STRIVE-2 neuroradiological classification of cerebral small vessel disease (2023). A clinical case report is presented of a 63-yearold female patient with mild VCI against a background of arterial hypertension, type 2 diabetes mellitus and obesity, in whom brain MRI revealed multiple lacunar infarcts and leukoaraiosis. The prescription of ethylmethylhydroxypyridine succinate in a new prolonged-release form (Armadin Long) is justified. The drug’s multimodal mechanism of action (antioxidant, antihypoxic, neuroprotective) corresponds to the key pathogenetic mechanisms of VCI, which justifies the choice of this drug for long-term treatment of cognitive disorders.

Рассмотрены современные подходы к диагностике и лечению сосудистых когнитивных нарушений (СКН). Приведены основные положения обновленных диагностических критериев СКН международного общества VasCog-2-WSO (2025) и нейрорадиологическая классификация церебральной микроангиопатии STRIVE-2 (2023). Представлено клиническое наблюдение пациентки 63 лет с умеренными СКН на фоне артериальной гипертензии, сахарного диабета 2-го типа и ожирения, у которой по данным МРТ головного мозга выявлены множественные лакунарные инфаркты и лейкоареоз. Обосновано назначение этилметилгидроксипиридина сукцината в новой пролонгированной лекарственной форме (Армадин лонг). Мультимодальный механизм действия препарата (антиоксидантный, антигипоксический, нейропротективный) соответствует ключевым патогенетическим механизмам СКН, что делает обоснованным выбор данного препарата для длительной терапии когнитивных расстройств.

хроническая ишемия мозгадисциркуляторная энцефалопатиясосудистые когнитивные нарушениянейропротективная терапияchronic cerebrovascular disordercerebrovascular insufficiencyvascular cognitive impairmentneuroprotective therapyСтатья спонсируется компанией «Гедеон Рихтер».The article is sponsored by Gedeon Richter.ReferencesRizzi L, Rosset I, Roriz-Cruz M. Global epidemiology of dementia: Alzheimer‘s and vascular types. Biomed Res Int. 2014;2014:908915. doi: 10.1155/2014/908915Rizzi L, Rosset I, Roriz-Cruz M. Global epidemiology of dementia: Alzheimer‘s and vascular types. Biomed Res Int. 2014;2014:908915. doi: 10.1155/2014/908915Sachdev PS, Bentvelzen AC, Kochan NA, et al.; VasCog-2-WSO Criteria Consortium. Revised diagnostic criteria for vascular cognitive impairment and dementia – the VasCog-2- WSO criteria. JAMA Neurol. 2025;82(11):1103- 12. doi: 10.1001/jamaneurol.2025.3242Sachdev PS, Bentvelzen AC, Kochan NA, et al.; VasCog-2-WSO Criteria Consortium. Revised diagnostic criteria for vascular cognitive impairment and dementia – the VasCog-2- WSO criteria. JAMA Neurol. 2025;82(11):1103- 12. doi: 10.1001/jamaneurol.2025.3242American Psychiatric Association. Diagnostic and statistical manual of mental disorders. 5th ed. Arlington: American Psychiatric Publishing; 2013. 947 p.American Psychiatric Association. Diagnostic and statistical manual of mental disorders. 5th ed. Arlington: American Psychiatric Publishing; 2013. 947 p.Reitan RM. Validity of the Trail Making test as an indicator of organic brain damage. Percept Mot Skills. 1958;8(3):271-6. doi: 10.2466/pms.1958.8.3.271Reitan RM. Validity of the Trail Making test as an indicator of organic brain damage. Percept Mot Skills. 1958;8(3):271-6. doi: 10.2466/pms.1958.8.3.271Kiely KM, Butterworth P, Watson N, Wooden M. The Symbol Digit Modalities Test: normative data from a large nationally representative sample of Australians. Arch Clin Neuropsychol. 2014;29(8):767-75. doi: 10.1093/arclin/acu055Kiely KM, Butterworth P, Watson N, Wooden M. The Symbol Digit Modalities Test: normative data from a large nationally representative sample of Australians. Arch Clin Neuropsychol. 2014;29(8):767-75. doi: 10.1093/arclin/acu055Cristofori I, Cohen-Zimerman S, Grafman J. Executive functions. Handb Clin Neurol. 2019;163:197-219. doi: 10.1016/B978-0-12-804281-6.00011-2Cristofori I, Cohen-Zimerman S, Grafman J. Executive functions. Handb Clin Neurol. 2019;163:197-219. doi: 10.1016/B978-0-12-804281-6.00011-2Захаров ВВ, редактор. Поведенческая неврология. Санкт-Петербург: Скифияпринт; Москва: Профмедпресс; 2022. 320 с.Zakharov VV, editor. Behavioral neurology. St. Petersburg: Skifiya-print; Moscow: Profmedpress; 2022. 320 p. (In Russ.).Dubois B, Slachevsky A, Litvan I, Pillon B. The FAB: a Frontal Assessment Battery at bedside. Neurology. 2000;55(11):1621-6. doi: 10.1212/wnl.55.11.1621Dubois B, Slachevsky A, Litvan I, Pillon B. The FAB: a Frontal Assessment Battery at bedside. Neurology. 2000;55(11):1621-6. doi: 10.1212/wnl.55.11.1621Хомская ЕД. Нейропсихология. СанктПетербург: Питер; 2005. 496 с.Khomskaya ED. Neuropsychology. St. Petersburg: Piter; 2005. 496 p. (In Russ.).Stroop JR. Studies of interference in serial verbal reactions. J Exp Psychol. 1935;18(6):643- 62. doi: 10.1037/h0054651Stroop JR. Studies of interference in serial verbal reactions. J Exp Psychol. 1935;18(6):643- 62. doi: 10.1037/h0054651Захаров ВВ, Вознесенская ТГ. Нервнопсихические нарушения: диагностические тесты. Москва: МЕДпресс-информ; 2013. 320 с.Zakharov VV, Voznesenskaya TG. Neuropsychiatric disorders: diagnostic tests. Moscow: MEDpress-inform; 2013. 320 p. (In Russ.).Gainotti G, Trojano L. Constructional apraxia. Handb Clin Neurol. 2018;151:331-48. doi: 10.1016/B978-0-444-63622-5.00016-4Gainotti G, Trojano L. Constructional apraxia. Handb Clin Neurol. 2018;151:331-48. doi: 10.1016/B978-0-444-63622-5.00016-4Федотова СЛ, Быков ЮН. Клинико-диагностическая характеристика сосудистого паркинсонизма. Сибирский медицинский журнал. 2014;(1):24-7.Fedotova SL, Bykov YuN. Clinical and diagnostic characteristics of vascular parkinsonism. Sibirskiy meditsinskiy zhurnal. 2014;(1):24-7 (In Russ.).Вознесенская ТГ. Депрессия при сосудистых заболеваниях головного мозга. Медицинский совет. 2012;(4):12-5.Voznesenskaya TG. Depression in cerebrovascular diseases. Medical Council. 2012;(4):12-5 (In Russ.).Alexopoulos GS, Meyers BS, Young RC, et al. “Vascular depression” hypothesis. Arch Gen Psychiatry. 1997 Oct;54(10):915-22. doi: 10.1001/archpsyc.1997.01830220033006Alexopoulos GS, Meyers BS, Young RC, et al. “Vascular depression” hypothesis. Arch Gen Psychiatry. 1997 Oct;54(10):915-22. doi: 10.1001/archpsyc.1997.01830220033006Боголепова АН. Сосудистая депрессия и когнитивная дисфункция. Неврология, нейропсихиатрия, психосоматика. 2019;11(S3):26-31. doi: 10.14412/2074-2711-2019-3S-26-31Bogolepova AN. Vascular depression and cognitive dysfunction. Nevrologiya, neiropsikhiatriya, psikhosomatika = Neurology, Neuropsychiatry, Psychosomatics. 2019;11(S3):26-31 (In Russ.). doi: 10.14412/2074-2711-2019-3S-26-31Левин ОС. Депрессия и деменция у пожилых пациентов. Современная терапия и психиатрия в неврологии. 2012;(4):39-44.Levin OS. Depression and dementia in elderly patients. Sovremennaya terapiya i psikhiatriya v nevrologii. 2012;(4):39-44 (In Russ.).Duering M, Biessels GJ, Brodtmann A, et al. Neuroimaging standards for research into small vessel disease – advances since 2013. Lancet Neurol. 2023;22(7):602-18. doi: 10.1016/S1474-4422(23)00131-XDuering M, Biessels GJ, Brodtmann A, et al. Neuroimaging standards for research into small vessel disease – advances since 2013. Lancet Neurol. 2023;22(7):602-18. doi: 10.1016/S1474-4422(23)00131-XGore M, Bansal K, Khan Suheb MZ, et al. Lacunar stroke. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025. PMID: 33085363.Gore M, Bansal K, Khan Suheb MZ, et al. Lacunar stroke. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025. PMID: 33085363.Fanning JP, Wesley AJ, Wong AA, Fraser JF. Emerging spectra of silent brain infarction. Stroke. 2014;45(11):3461-71. doi: 10.1161/STROKEAHA.114.005919Fanning JP, Wesley AJ, Wong AA, Fraser JF. Emerging spectra of silent brain infarction. Stroke. 2014;45(11):3461-71. doi: 10.1161/STROKEAHA.114.005919Fisher CM. Lacunes: small, deep cerebral infarcts. Neurology. 1965;15:774-84. doi: 10.1212/wnl.50.4.841-aFisher CM. Lacunes: small, deep cerebral infarcts. Neurology. 1965;15:774-84. doi: 10.1212/wnl.50.4.841-aYaghi S, Raz E, Yang D, et al. Lacunar stroke: mechanisms and therapeutic implications. J Neurol Neurosurg Psychiatry. 2021;92(8):823-30. doi: 10.1136/jnnp-2021-326308Yaghi S, Raz E, Yang D, et al. Lacunar stroke: mechanisms and therapeutic implications. J Neurol Neurosurg Psychiatry. 2021;92(8):823-30. doi: 10.1136/jnnp-2021-326308Carey CL, Kramer JH, Josephson SA, et al. Subcortical lacunes are associated with executive dysfunction in cognitively normal elderly. Stroke. 2008;39(2):397-402. doi: 10.1161/STROKEAHA.107.500785Carey CL, Kramer JH, Josephson SA, et al. Subcortical lacunes are associated with executive dysfunction in cognitively normal elderly. Stroke. 2008;39(2):397-402. doi: 10.1161/STROKEAHA.107.500785Sole-Guardia G, Tuladhar AM, de Leeuw FE. Cortical cerebral microinfarcts spark cognitive decline. Brain. 2025;148(11):3789- 91. doi: 10.1093/brain/awaf377Sole-Guardia G, Tuladhar AM, de Leeuw FE. Cortical cerebral microinfarcts spark cognitive decline. Brain. 2025;148(11):3789- 91. doi: 10.1093/brain/awaf377Li Q, Yang Y, Reis C, et al. Cerebral small vessel disease. Cell Transplant. 2018;27(12):1711-22. doi: 10.1177/0963689718795148Li Q, Yang Y, Reis C, et al. Cerebral small vessel disease. Cell Transplant. 2018;27(12):1711-22. doi: 10.1177/0963689718795148Das AS, Regenhardt RW, Vernooij MW, et al. Asymptomatic cerebral small vessel disease: insights from population-based studies. J Stroke. 2019;21(2):121-38. doi: 10.5853/jos.2018.03608Das AS, Regenhardt RW, Vernooij MW, et al. Asymptomatic cerebral small vessel disease: insights from population-based studies. J Stroke. 2019;21(2):121-38. doi: 10.5853/jos.2018.03608Левин ОС. Патология белого вещества при дисциркуляторной энцефалопатии: диагностические и терапевтические аспекты. Трудный пациент. 2011;(12):16-23.Levin OS. White matter pathology in dyscirculatory encephalopathy: diagnostic and therapeutic aspects. Trudnyy patsient. 2011;(12):16- 23 (In Russ.).Sudo FK, Amado P, Alves GS, et al. A continuum of executive function deficits in early subcortical vascular cognitive impairment: a systematic review and meta-analysis. Dement Neuropsychol. 2017;11(4):371-80. doi: 10.1590/1980-57642016dn11-040007Sudo FK, Amado P, Alves GS, et al. A continuum of executive function deficits in early subcortical vascular cognitive impairment: a systematic review and meta-analysis. Dement Neuropsychol. 2017;11(4):371-80. doi: 10.1590/1980-57642016dn11-040007Pasi M, Charidimou A, Boulouis G, et al. Mixed-location cerebral hemorrhage/microbleeds: underlying microangiopathy and recurrence risk. Neurology. 2018;90(2):e119-e126. doi: 10.1212/WNL.0000000000004797Pasi M, Charidimou A, Boulouis G, et al. Mixed-location cerebral hemorrhage/microbleeds: underlying microangiopathy and recurrence risk. Neurology. 2018;90(2):e119-e126. doi: 10.1212/WNL.0000000000004797Cui Y, Zhao T, Zhang W, et al. Risk factor analysis in patients exhibiting cerebral microbleeds and the correlation with cognitive impairment. J Gerontol Geriatr Med. 2024;10(2):23337214241278497. doi: 10.1177/23337214241278497Cui Y, Zhao T, Zhang W, et al. Risk factor analysis in patients exhibiting cerebral microbleeds and the correlation with cognitive impairment. J Gerontol Geriatr Med. 2024;10(2):23337214241278497. doi: 10.1177/23337214241278497Hoskin J, Al Azzawi H, Huynh C, et al. Superficial siderosis. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2024. PMID: 35015416.Hoskin J, Al Azzawi H, Huynh C, et al. Superficial siderosis. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2024. PMID: 35015416.Doubal FN, MacLullich AM, Ferguson KJ, et al. Enlarged perivascular spaces on MRI are a feature of cerebral small vessel disease. Stroke. 2010;41(3):450-4. doi: 10.1161/STROKEAHA.109.564914Doubal FN, MacLullich AM, Ferguson KJ, et al. Enlarged perivascular spaces on MRI are a feature of cerebral small vessel disease. Stroke. 2010;41(3):450-4. doi: 10.1161/STROKEAHA.109.564914Hernandez Mdel C, Piper RJ, Wang X, et al. Towards the automatic computational assessment of enlarged perivascular spaces on brain magnetic resonance images: a systematic review. J Magn Reson Imaging. 2013;38(4):774- 85. doi: 10.1002/jmri.24047Hernandez Mdel C, Piper RJ, Wang X, et al. Towards the automatic computational assessment of enlarged perivascular spaces on brain magnetic resonance images: a systematic review. J Magn Reson Imaging. 2013;38(4):774- 85. doi: 10.1002/jmri.24047Когнитивные расстройства у лиц пожилого и старческого возраста: клинические рекомендации. Москва: Министерство здравоохранения Российской Федерации; 2020. 149 с.Ministry of Health of the Russian Federation. Cognitive disorders in elderly and senile persons: clinical guidelines. Moscow: Ministry of Health of the Russian Federation; 2020. 149 p. (In Russ.).Jellinger KA. Pathology and pathogenesis of vascular cognitive impairment – a critical update. Front Aging Neurosci. 2013;5:17. doi: 10.3389/fnagi.2013.00017Jellinger KA. Pathology and pathogenesis of vascular cognitive impairment – a critical update. Front Aging Neurosci. 2013;5:17. doi: 10.3389/fnagi.2013.00017Luca M, Luca A, Calandra C. The role of oxidative damage in the pathogenesis and progression of Alzheimer‘s disease and vascular dementia. Oxid Med Cell Longev. 2015;2015:504678. doi: 10.1155/2015/504678Luca M, Luca A, Calandra C. The role of oxidative damage in the pathogenesis and progression of Alzheimer‘s disease and vascular dementia. Oxid Med Cell Longev. 2015;2015:504678. doi: 10.1155/2015/504678Шишкова ВН, Приходько ВА, Оковитый СВ. Выбор современного нейропротекторного препарата как базовая стратегия в терапии хронических цереброваскулярных заболеваний. Медицинский совет. 2023;17(10):41-9. doi: 10.21518/ms2023-232Shishkova VN, Prikhodko VA, Okovityi SV. The choice of a modern neuroprotective drug as a basic strategy in the treatment of chronic cerebrovascular diseases. Medical Council. 2023;17(10):41-9 (In Russ.). doi: 10.21518/ms2023-232Остроумова ОД, Плотникова НА, Кочетков АИ и др. Этилметилгидроксипиридина сукцинат и доказательная нейропротекция: тенденции и перспективы. Медицинский алфавит. 2025;(36):7-13. doi: 10.33667/2078-5631-2025-36-7-13Ostroumova OD, Plotnikova NA, Kochetkov AI, et al. Ethylmethylhydroxypyridine succinate and evidence-based neuroprotection: trends and perspectives. Meditsinskiy alfavit. 2025;(36):7-13 (In Russ.). doi: 10.33667/2078-5631-2025-36-7-13

The authors declare that there are no conflicts of interest present.